New administration building opens, reinforcing DVCR’s commitment to operational excellence and a thriving team culture.

Dr. Vince Clinical Research (DVCR), a fast-growing contract research organization (CRO), is proud to announce the official opening of its new 5,000-square-foot administration building, located on its flagship research campus in Overland Park, Kansas. The expansion marks a major milestone in DVCR’s ongoing investment in its people, infrastructure and the future of early phase clinical research.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250724651877/en/

New administrative building on the campus of Dr. Vince Clinical Research, located at 7401 W. 91st Street, Overland Park, KS 66212.

“DVCR first opened its doors in late 2022, and in less than three years, we have grown to approximately 250 employees globally. That growth—combined with being awarded over 100 clinical trials across Phases I through IV—is a true testament to the dedication of our team and the trust our clients place in us,” said Dr. Brad Vince, CEO and Chief Medical Officer at DVCR.

The new building, which will be celebrated with an employee open house, will be home to DVCR’s finance, human resources, marketing and volunteer recruitment teams. Strategically located on the existing 75,000-square-foot campus, the building mirrors the headquarters’ architectural style to ensure a seamless and unified environment for employees and visitors alike.

“As we continue to attract new biopharmaceutical clients as well as talented clinical researchers, scaling our campus appropriately is essential,” said Dr. Vince. “This new facility supports the operational base needed to sustain our momentum and underscores our long-term commitment to the clinical research industry.”

The project received unanimous approval from the Overland Park Planning Commission in March 2024 and broke ground in January 2025. Completion of the new building comes in under a year, underscoring DVCR’s efficient execution and momentum as a CRO leader.

About Dr. Vince Clinical Research

Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas such as neuroscience, substance abuse, pain, cardiometabolic disorders, infectious diseases and many others. CRO services include project management, data management, biostatistics, statistical programming, PK/PD analysis, medical writing, clinical and medical monitoring as well as site feasibility and management for multi-site trials with our global network of site partners. Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a cGMP compliant pharmacy as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to its biopharmaceutical clients.

For more information, visit: https://drvince.com/cro

Connect with DVCR on LinkedIn and YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20250724651877/en/

This new facility supports the operational base needed to sustain our momentum and underscores our long-term commitment to the clinical research industry.